Results 1 to 10 of about 96,614 (276)

Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy [PDF]

Clinical Medicine Insights: Oncology, 2016
Introduction Temozolomide and concomitant radiotherapy followed by temozolomide has been used as a standard therapy for the treatment of newly diagnosed glioblastoma multiform since 2005. A search for prognostic factors was conducted in patients with glioblastoma routinely treated by this strategy in our ...
Clotilde Verlut, Guillaume Mouillet, Eloi Magnin, Joëlle Buffet-Miny, Gabriel Viennet, Françoise Cattin, Nora Clelia Billon-Grand, Emilie Bonnet, Stéphanie Servagi-Vernat, Joël Godard, Romain Billon-Grand, Antoine Petit, Thierry Moulin, Laurent Cals, Xavier Pivot, Elsa Curtit   +15 more
doaj   +10 more sources

Does the Score on the MRC Strength Scale Reflect Instrumented Measures of Maximal Torque and Muscle Activity in Post-Stroke Survivors? [PDF]

Sensors, 2021
It remains unknown whether variation of scores on the Medical Research Council (MRC) scale for muscle strength is associated with operator-independent techniques: dynamometry and surface electromyography (sEMG).
Pawel Kiper, Daniele Rimini, Deborah Falla, Alfonc Baba, Sebastian Rutkowski, Lorenza Maistrello, Andrea Turolla   +6 more
doaj   +10 more sources

The MRC Dyspnoea Scale and mortality risk prediction in pulmonary arterial hypertension: A retrospective longitudinal cohort study [PDF]

Pulmonary Circulation, 2023
Risk stratification models in pulmonary arterial hypertension (PAH) rely on World Health Organisation Functional Class (WHO FC). A high proportion of patients are classified as WHO FC III, a heterogenous group which limits the stratification abilities of
Folawemimo Arogundade, Bhautesh Jani, Colin Church, Melanie Brewis, Martin Johnson, Harrison Stubbs   +5 more
doaj   +5 more sources

Detecting respiratory impairment in newly diagnosed rheumatoid arthritis by MRC dyspnoea scale and microfibrillar-associated protein 4 [PDF]

European Clinical Respiratory Journal
Objectives To evaluate the Medical Research Council (MRC) dyspnoea scale and serum Microfibrillar-associated protein 4 (MFAP4) levels for the detection of respiratory impairment in newly diagnosed rheumatoid arthritis (RA).Methods Patients underwent ...
Bjørk K. Sofiudottir, Sören Möller, Robin Christensen, Stefan Harders, Grith L. Sørensen, Jesper Blegvad, Mette Herly, Dzenan Masic, Grazina Urbonaviciene, Frank Andersen, Christin Isaksen, Brian Bridal Løgstrup, Charlotte Hyldgaard, Torkell Ellingsen   +13 more
doaj   +6 more sources

Interferon Inhibition Enhances the Pilot-Scale Production of Rabies Virus in Human Diploid MRC-5 Cells [PDF]

Viruses, 2021
Inactivated vaccines based on cell culture are very useful in the prevention and control of many diseases. The most popular strategy for the production of inactivated vaccines is based on monkey-derived Vero cells, which results in high productivity of ...
Xiao Yang, Mingming Wan, Linjun Cai, Ali Hou, Bo Sun, Yan Zhou, Feng Gao, Weiheng Su, Chunlai Jiang   +8 more
doaj   +4 more sources

The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients [PDF]

Respiratory Medicine, 2010
Dyspnoea is the most common symptom associated with poor quality of life in patients affected by Chronic Obstructive Pulmonary Disease (COPD). While COPD severity is commonly staged by lung function, the Medical Research Council (MRC) dyspnoea scale has been proposed as a more clinically meaningful method of quantifying disease severity in COPD.
Rick Hodder, Vincenzo Bellia, Raffaele Antonelli Incalzi   +2 more
exaly   +4 more sources

Internal consistency, construct validity, and responsiveness of the MRC Prion Disease Rating Scale

Journal of Patient-Reported Outcomes
Background The Medical Research Council-Prion Disease Rating Scale (MRC-PDRS) is a 20-point clinician-reported outcome scale to assess disease progression in patients with prion disease, an invariably fatal neurodegenerative disease caused by misfolded ...
Leah Leidy, Aaron Yarlas, Robert S. Pulido, Jessica Ludwig, Kathleen Glisic, Brian S. Appleby   +5 more
doaj   +4 more sources

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [PDF]

Thorax, 1999
Methods of classifying chronic obstructive pulmonary disease (COPD) depend largely upon spirometric measurements but disability is only weakly related to measurements of lung function. With the increased use of pulmonary rehabilitation, a need has been identified for a simple and standardised method of categorising disability in COPD.
E A Paul, R Garrod
exaly   +3 more sources

Post-COVID-19 Muscle Weakness and Recovery Patterns After Mild-to-Moderate Infection: A Retrospective Analysis of a Structured Rehabilitation Program Using the MRC Scale. [PDF]

Healthcare (Basel)
Background/Objectives: Post-COVID-19 muscle weakness is common even after mild or moderate infection, driven by systemic inflammation, prolonged inactivity, and reduced functional reserve. This study aimed to describe changes in global muscle strength assessed using the Medical Research Council (MRC) scale in adults recovering from mild or moderate ...
Chiriac OC, Miricescu D, Mititelu R, Stanciu SM, Sporea C, Mitrea AR, Lunca DC, Nica SA, Popa CC, Vacaroiu IA.   +9 more
europepmc   +3 more sources

Development of a user guide to support administration of the MRC Prion Disease Rating Scale in research and clinical settings for prion diseases

Prion
Background The prion diseases (PrD) are a group of progressive, fatal, neurodegenerative diseases, for which the Medical Research Council Prion Disease Rating Scale (MRC Scale) can be used to assess patients’ functional deterioration.
Robert S. Pulido, Chris Marshall, Anne V. Smith, Hannah Edge, Aaron Yarlas, Brian Appleby, Jean-Philippe Brandel, Steven Collins, Nurit Omer, Inga Zerr, Simon Mead   +10 more
doaj   +4 more sources